MS-12 TEMOZOLOMIDE-BASED THERAPY FOR THE MANAGEMENT OF PROGRESSIVE PITUITARY CARCINOMA

BACKGROUND: Pituitary carcinomas (PC) are very uncommon, accounting for only 0.1 % of all pituitary tumors and representing a treatment challenge. Diagnosis is based on presence of intra- and/or extracranial metastases. PC is resistant to current treatment regimens, with a median overall survival of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kamiya-Matsuoka, Carlos, Cachia, David, Waguespack, Steven G., McCutcheon, Ian E., Mahajan, Anita, Brown, Paul D., Groves, Morris D., Penas-Prado, Marta
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2014
Schlagworte:
Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218266/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou260.11
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge